USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
USANA Health Sciences, Inc.NYSE: USNA
Selling, General & Admin · Q1 FY2026 · quarter ended Apr 2026
Selling, general & admin declines year over year
Q1 FY2026 selling, general & admin of $88.25M fell 49.0% year over year, behind the -34.2% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 13.0% from the prior quarter. Over 3 fiscal years it compounded at -20.5% a year.
Context
- Selling, general & admin amounted to 36.5% of revenue in FY2025, down 33.9 pp from a year earlier.
- Selling, general & admin increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $552.81M (+63.9%) for the fiscal year ending Jan 2027, a step up from the -43.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $88.25M+13.0% QoQ
- Last fiscal yearJan 2026
- $337.37M-43.9% YoY
- LTMApr 2026
- $413.49M-34.2% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 337.37M USD
- Year-over-year change
- -43.9%
- 4-year CAGR
- -18.8%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 337.37M | -43.9% |
| FY2024 | 2024-12-28 | 600.86M | -4.2% |
| FY2023 | 2023-12-31 | 627.1M | -6.7% |
| FY2022 | 2022-12-31 | 672.14M | -13.2% |
| FY2021 | 2021-12-31 | 774.23M | — |
Selling, General & Admin vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -34.2% is the lowest of 8, against a peer median of -0.7%.
- Selling, general & admin amounts to 44.7% of revenue for USNA, versus a peer median of 17.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥766.05M CNY | -19.7% | -4.9% | 4.0% | |
| LTM Apr 2026 | $413.49M USD | -34.2% | -20.5% | 44.7% | |
| LTM Apr 2026 | $186.69M USD | -0.7% | -1.2% | 10.3% | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | $182.97M USD | +1.1% | +12.6% | 14.3% |
| LTM Mar 2026 | $134.02M USD | -9.0% | -17.4% | 32.1% | |
| LTM Mar 2026 | R$94.11M BRL | -10.0% | -38.4% | 17.2% | |
| LTM Mar 2026 | $43.06M USD | +20.7% | +20.2% | 18.8% | |
| LTM Apr 2026 | $37.79M USD | +44.5% | +29.4% | 20.0% | |
| Peer median (excluding USNA) | — | -0.7% | -1.2% | 17.2% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.19B | 998.6M | 921.01M | 854.5M | 925.26M |
| Cost of Revenue | 230.93M | 207.28M | 189.4M | 175.75M | 200.85M |
| Gross Profit | 955.53M | 791.32M | 731.62M | 678.75M | 724.41M |
| Gross Margin | 80.5% | 79.2% | 79.4% | 79.4% | 78.3% |
| Research & Development | 11.11M | 11.56M | 11.45M | 11.57M | 0 |
| Selling, General & Admin | 774.23M | 672.14M | 627.1M | 600.86M | 337.37M |
| Operating Expenses | 785.34M | 683.7M | 638.54M | 612.43M | 673.54M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 39.7M |
| EBITDA | 192.89M | 130.22M | 123.11M | 98.86M | 82.07M |
| EBITDA Margin | 16.3% | 13.0% | 13.4% | 11.6% | 8.9% |
| Operating Income | 170.19M | 107.61M | 93.07M | 66.32M | 50.86M |
| Operating Margin | 14.3% | 10.8% | 10.1% | 7.8% | 5.5% |
| Interest Income | 2.52M | 3.79M | 9.64M | 11.32M | 2.42M |
| Interest Expense | 57K | 192K | 262K | 281K | 842K |
| Other Income / Expenses | 450K | 1.01M | 9.38M | 10.03M | (9.34M) |
| Income Before Tax | 170.64M | 108.62M | 102.45M | 76.35M | 41.53M |
| Pre-Tax Margin | 14.4% | 10.9% | 11.1% | 8.9% | 4.5% |
| Income Tax Expense | 54.14M | 39.27M | 38.67M | 34.29M | 30.05M |
| Net Income | 116.51M | 69.35M | 63.79M | 42.03M | 10.76M |
| Net Margin | 9.8% | 6.9% | 6.9% | 4.9% | 1.2% |
| EPS (Basic) | 5.78 | 3.60 | 3.33 | 2.20 | 0.58 |
| EPS (Diluted) | 5.73 | 3.59 | 3.30 | 2.19 | 0.58 |
| Weighted Avg Shares | 20.15M | 19.25M | 19.25M | 19.06M | 18.57M |
| Weighted Avg Shares (Diluted) | 20.34M | 19.31M | 19.35M | 19.16M | 18.57M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.